APA (7th ed.) Citation

C, T., JR, M., M, M., N, K., S, H., MD, P., . . . AP, H. (2022). Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. British journal of pharmacology, 179(11), 2631. https://doi.org/10.1111/bph.15757

Chicago Style (17th ed.) Citation

C, TeBay, McArthur JR, Mangala M, Kerr N, Heitmann S, Perry MD, Windley MJ, Vandenberg JI, and Hill AP. "Pathophysiological Metabolic Changes Associated with Disease Modify the Proarrhythmic Risk Profile of Drugs with Potential to Prolong Repolarisation." British Journal of Pharmacology 179, no. 11 (2022): 2631. https://doi.org/10.1111/bph.15757.

MLA (9th ed.) Citation

C, TeBay, et al. "Pathophysiological Metabolic Changes Associated with Disease Modify the Proarrhythmic Risk Profile of Drugs with Potential to Prolong Repolarisation." British Journal of Pharmacology, vol. 179, no. 11, 2022, p. 2631, https://doi.org/10.1111/bph.15757.